Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-02-05 @ 10:27 AM
Study NCT ID:
NCT00513669
Status:
COMPLETED
Last Update Posted:
2013-03-15
First Post:
2007-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
Sponsor:
Swiss Tropical & Public Health Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PMAL03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None